Spero Therapeutics (SPRO) Cash from Investing Activities (QoQ) (2018 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -100.26% |
| Jun 30, 2022 | 411.25% |
| Mar 31, 2022 | 30.98% |
| Dec 31, 2021 | -236.71% |
| Sep 30, 2021 | 55.92% |
| Jun 30, 2021 | 263.60% |
| Mar 31, 2021 | 107.56% |
| Dec 31, 2020 | -1,106.33% |
| Sep 30, 2020 | -78.64% |
| Jun 30, 2020 | -33.45% |
| Mar 31, 2020 | 777.63% |
| Dec 31, 2019 | 74.20% |
| Sep 30, 2019 | -163.94% |
| Jun 30, 2019 | 0.71% |
| Mar 31, 2019 | 238.56% |
| Dec 31, 2018 | 110.03% |
| Sep 30, 2018 | -1,552.36% |
| Jun 30, 2018 | 121.91% |